title: Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis.
abstract: In an autopsy case of galactosialidosis, GM3, GM2, GM1, and GD1a were accumulated in sympathetic and spinal ganglia and grey matter of the spinal cord. Especially, the accumulations of GM3 and GM2 amounted to 41- and 86-fold increases in sympathetic ganglia, respectively, as compared to normal controls. In addition LacCer, GA2 and GA1 were accumulated in sympathetic and spinal ganglia. The accumulations of GM3 and GD1a are considered to be the result of defective lysosomal sialidase activity and the accumulation of GM1, LacCer and GA1 is also considered to be due to decreased beta-galactosidase activity in this disorder. To better understand the possible mechanism of GM2 accumulation, we determined the activity of GM2 synthesizing enzyme (GM3:UDP-GalNAc transferase), as well as hexosaminidase activity, in sympathetic ganglia, but they did not change. Abnormal ganglioside and neutral glycosphingolipid metabolism, as well as sialyloligosaccharide and sialylglycoprotein metabolism, may be involved in the pathogenesis of this disorder.
authors.affiliation: Department of Neurology, Niigata University, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Yoshino
authors.forename: K
authors.initials: K
authors.lastname: Miyashita
authors.forename: N
authors.initials: N
authors.lastname: Miyatani
authors.forename: T
authors.initials: T
authors.lastname: Ariga
authors.forename: Y
authors.initials: Y
authors.lastname: Hashimoto
authors.forename: S
authors.initials: S
authors.lastname: Tsuji
authors.forename: K
authors.initials: K
authors.lastname: Oyanagi
authors.forename: E
authors.initials: E
authors.lastname: Ohama
authors.forename: F
authors.initials: F
authors.lastname: Ikuta
authors.forename: A
authors.initials: A
authors.lastname: Suzuki
mesh_terms: D001696:Biomechanical Phenomena; D001921:Brain / Q000378:metabolism; D002648:Child; D005678:G(M2) Ganglioside / Q000378:metabolism; D005690:Galactose / Q000172:deficiency*; D005696:Galactosidases / Q000172:deficiency*; D005697:Galactosides / Q000378:metabolism; D005727:Ganglia, Spinal / Q000378:metabolism; D005728:Ganglia, Sympathetic / Q000378:metabolism; D006017:Glycolipids / Q000378:metabolism; D006028:Glycosphingolipids / Q000378:metabolism*; D006801:Humans; D008297:Male; D009420:Nervous System / Q000378:metabolism*; D001616:beta-Galactosidase / Q000172:deficiency*
chemical_list: D005697:Galactosides; D006017:Glycolipids; D006028:Glycosphingolipids; D005678:G(M2) Ganglioside; D005696:Galactosidases; D001616:beta-Galactosidase; D005690:Galactose